Pharmena S.A. (PHR) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.078x

Based on the latest financial reports, Pharmena S.A. (PHR) has a cash flow conversion efficiency ratio of -0.078x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-820.00K ≈ $-225.68K USD) by net assets (zł10.54 Million ≈ $2.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see PHR company net worth for the company's overall valuation and market capitalisation.

Pharmena S.A. - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Pharmena S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pharmena S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmena S.A. ranked by their cash flow conversion efficiency. Explore PHR cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
The European Smaller Companies Trust PLC LSE:ESCT	-0.003x
Duketon Mining Ltd AU:DKM	-0.008x
Obm Drilchem PT JK:OBMD	0.006x
Culpeo Minerals Ltd AU:CPO	-0.105x
HiteJinro Co Ltd KO:000087	0.090x
Zhuhai Sailong Pharmaceutical Co Ltd SHE:002898	-0.076x
CytoMed Therapeutics Limited Ordinary Shares NASDAQ:GDTC	-0.299x
ESSA Pharma Inc NASDAQ:EPIX	-0.039x

Annual Cash Flow Conversion Efficiency for Pharmena S.A. (2008–2024)

The table below shows the annual cash flow conversion efficiency of Pharmena S.A. from 2008 to 2024. View Pharmena S.A. (PHR) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł12.42 Million ≈ $3.42 Million	zł-2.53 Million ≈ $-696.57K	-0.204x	-113.71%
2023-12-31	zł22.23 Million ≈ $6.12 Million	zł33.03 Million ≈ $9.09 Million	1.486x	+654.93%
2022-12-31	zł-6.79 Million ≈ $-1.87 Million	zł1.82 Million ≈ $500.62K	-0.268x	-142.53%
2021-12-31	zł-5.12 Million ≈ $-1.41 Million	zł-3.23 Million ≈ $-887.57K	0.630x	-90.23%
2020-12-31	zł-348.00K ≈ $-95.77K	zł-2.24 Million ≈ $-617.31K	6.445x	+344.95%
2019-12-31	zł5.00 Million ≈ $1.37 Million	zł-13.15 Million ≈ $-3.62 Million	-2.631x	-241.00%
2018-12-31	zł1.94 Million ≈ $532.82K	zł3.61 Million ≈ $994.35K	1.866x	+973.60%
2017-12-31	zł3.56 Million ≈ $980.04K	zł619.00K ≈ $170.36K	0.174x	+208.74%
2016-12-31	zł5.94 Million ≈ $1.64 Million	zł-950.00K ≈ $-261.45K	-0.160x	+66.80%
2015-12-31	zł8.67 Million ≈ $2.39 Million	zł-4.17 Million ≈ $-1.15 Million	-0.481x	-9.53%
2014-12-31	zł13.08 Million ≈ $3.60 Million	zł-5.75 Million ≈ $-1.58 Million	-0.440x	-106.82%
2013-12-31	zł18.05 Million ≈ $4.97 Million	zł-3.84 Million ≈ $-1.06 Million	-0.213x	+52.93%
2012-12-31	zł8.98 Million ≈ $2.47 Million	zł-4.05 Million ≈ $-1.12 Million	-0.451x	-1213.85%
2011-12-31	zł16.45 Million ≈ $4.53 Million	zł666.91K ≈ $183.54K	0.041x	+159.65%
2010-12-31	zł15.91 Million ≈ $4.38 Million	zł-1.08 Million ≈ $-297.50K	-0.068x	-512.69%
2009-12-31	zł16.16 Million ≈ $4.45 Million	zł-179.22K ≈ $-49.32K	-0.011x	-437.74%
2008-12-31	zł15.78 Million ≈ $4.34 Million	zł-32.56K ≈ $-8.96K	-0.002x	--

About Pharmena S.A.

WAR:PHR Poland Biotechnology

Market Cap

$9.53 Million

zł34.64 Million PLN

Market Cap Rank

#27274 Global

#292 in Poland

Share Price

zł3.11

Change (1 day)

-0.64%

52-Week Range

zł2.55 - zł4.22

All Time High

zł28.01